Sub-10¢ Watch: 10 Stocks That Could Explode — July 8, 2026

Introduction In the world of penny stocks, opportunities abound, but so do risks. Stocks trading under $0.10 often have low floats and high volatility, making them appealing for speculative investors. Here, we examine ten stocks that could experience significant price movements in the near term based on various factors.

1. SNDL - Sundial Growers Inc. - **Current Price**: $0.08 - **Sector**: Cannabis - **Volume Profile**: Volume has seen a steady increase over the past month, indicating accumulation. - **Short Interest**: 20% of the float is shorted, suggesting high squeeze potential. - **Catalyst**: Potential legalization of cannabis in various states could trigger a rally. - **Technical Setup**: Recently bounced off support at $0.07. - **Risk Factors**: Regulatory changes or poor earnings could lead to further declines. - **Bull Case Price Target**: $0.15 (30-90 days) - **Risk Rating**: 🟡 High

2. MVIS - MicroVision, Inc. - **Current Price**: $0.09 - **Sector**: Technology - **Volume Profile**: Increasing volume suggests growing interest. - **Short Interest**: Approximately 25% of the float is shorted. - **Catalyst**: New product launches in LIDAR technology may boost investor sentiment. - **Technical Setup**: Currently breaking out of a consolidation phase. - **Risk Factors**: Competition and technological setbacks could hinder progress. - **Bull Case Price Target**: $0.20 (30-90 days) - **Risk Rating**: 🟡 High

3. CLOV - Clover Health Investments Corp. - **Current Price**: $0.06 - **Sector**: Healthcare - **Volume Profile**: Volume is gradually increasing, indicating accumulation. - **Short Interest**: 15% of the float is shorted. - **Catalyst**: Upcoming earnings report could surprise analysts positively. - **Technical Setup**: Recently bounced from a key support level at $0.05. - **Risk Factors**: Poor earnings or regulatory scrutiny could lead to losses. - **Bull Case Price Target**: $0.12 (30-90 days) - **Risk Rating**: 🟡 High

4. RIGL - Rigel Pharmaceuticals, Inc. - **Current Price**: $0.09 - **Sector**: Biotechnology - **Volume Profile**: Increased trading volume indicates accumulation. - **Short Interest**: 18% of the float is shorted. - **Catalyst**: Potential FDA approval for new treatments could drive shares higher. - **Technical Setup**: Trading near support at $0.08 with upward momentum. - **Risk Factors**: Clinical trial failures could negatively impact stock price. - **Bull Case Price Target**: $0.18 (30-90 days) - **Risk Rating**: 🟡 High

5. GERN - Geron Corporation - **Current Price**: $0.07 - **Sector**: Biotechnology - **Volume Profile**: Volume has been rising, indicating investor interest. - **Short Interest**: 22% of the float is shorted. - **Catalyst**: Positive clinical trial results could act as a major catalyst. - **Technical Setup**: Currently testing support levels at $0.06. - **Risk Factors**: Negative trial results could lead to significant losses. - **Bull Case Price Target**: $0.15 (30-90 days) - **Risk Rating**: 🟡 High

6. AITX - Artificial Intelligence Technology Solutions, Inc. - **Current Price**: $0.05 - **Sector**: Security Technology - **Volume Profile**: Increasing volume indicates accumulation. - **Short Interest**: 30% of the float is shorted. - **Catalyst**: New product launches in the AI security space could boost shares. - **Technical Setup**: Recently broke above resistance at $0.04. - **Risk Factors**: Market competition and technology adoption could limit growth. - **Bull Case Price Target**: $0.10 (30-90 days) - **Risk Rating**: 🟡 High

7. HCMC - Healthier Choices Management Corp. - **Current Price**: $0.04 - **Sector**: Consumer Goods - **Volume Profile**: Volume shows signs of accumulation. - **Short Interest**: 10% of the float is shorted. - **Catalyst**: Potential expansion into new markets could drive growth. - **Technical Setup**: Trading near support at $0.03. - **Risk Factors**: Market volatility and competition could hinder performance. - **Bull Case Price Target**: $0.08 (30-90 days) - **Risk Rating**: 🟢 Moderate

8. SIRC - Solar Integrated Roofing Corp. - **Current Price**: $0.09 - **Sector**: Renewable Energy - **Volume Profile**: Rising volume suggests accumulation. - **Short Interest**: 12% of the float is shorted. - **Catalyst**: Increasing demand for renewable energy solutions could drive growth. - **Technical Setup**: Recently bounced from support at $0.08. - **Risk Factors**: Regulatory changes and market competition could impact performance. - **Bull Case Price Target**: $0.15 (30-90 days) - **Risk Rating**: 🟡 High

9. VNTH - Ventoux CCM Acquisition Corp. - **Current Price**: $0.05 - **Sector**: SPAC - **Volume Profile**: Volume has been increasing, indicating interest. - **Short Interest**: 20% of the float is shorted. - **Catalyst**: Announcement of a merger could provide significant upside. - **Technical Setup**: Testing support at $0.04 with potential for upward movement. - **Risk Factors**: Merger failure could lead to a substantial drop. - **Bull Case Price Target**: $0.10 (30-90 days) - **Risk Rating**: 🟡 High

10. APHA - Aphria Inc. - **Current Price**: $0.09 - **Sector**: Cannabis - **Volume Profile**: Steady increase in volume indicating accumulation. - **Short Interest**: 14% of the float is shorted. - **Catalyst**: Potential merger with another cannabis company could drive growth. - **Technical Setup**: Recently broke out of a consolidation phase. - **Risk Factors**: Market sentiment and regulatory changes could affect price. - **Bull Case Price Target**: $0.15 (30-90 days) - **Risk Rating**: 🟡 High

Why These Price Ranges Matter Low-priced stocks, particularly those under $0.10, often have low floats, leading to significant volatility. This volatility can lead to rapid price movements, providing opportunities for traders. Moreover, these stocks often become targets for retail investors, especially when social media discussions gain traction.

How to Trade Them Safely Given the inherent risks, position sizing becomes crucial. Traders should only allocate a small percentage of their portfolio to these stocks. Utilizing limit orders can help manage entry points effectively. Monitoring catalyst timing is essential to maximize potential gains while mitigating risks.

Catalyst Calendar - **SNDL**: Cannabis legalization discussions in various states (Q3 2026) - **MVIS**: Product launch expected in August 2026 - **CLOV**: Earnings report on July 15, 2026 - **RIGL**: FDA announcement expected in late July 2026 - **GERN**: Clinical trial results expected mid-July 2026

These stocks represent high-risk speculative plays. Proper risk management is essential for potential success in trading these volatile assets.